Physician profile
Brooke Jackson
NPI 1457949851
$897.56
in general payments reported to CMS, 2019-2025
13 companies · $20.33 in 2025
The $20.33 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $274 · 2022: $471 · 2023: $21.18 · 2024: $111 · 2025: $20.33.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $152.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $152.21 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Myovant Sciences INC. | $397.82 | 2021-2022 | |
| Astellas Pharma US INC | $131.88 | 2023-2024 | Veozah |
| Abbvie INC. | $94.55 | 2022 | |
| Hologic Sales and Service, LLC | $58.41 | 2022 | |
| Daiichi Sankyo INC. | $43.07 | 2022 | |
| Therapeuticsmd, INC. | $38.57 | 2021 | |
| Evofem Biosciences, INC. | $30.53 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $20.46 | 2022 | |
| Biogen, INC. | $20.33 | 2025 | Zurzuvae |
| Sage Therapeutics, LLC | $17.26 | 2022 | |
| Mayne Pharma Commercial LLC | $16.12 | 2022 | |
| Exeltis, USA INC. | $14.41 | 2022 | |
| Allergan, INC. | $14.15 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brooke Jackson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.